C81.2

Clinical Causes: Unknown exact cause, but certain genetic and environmental factors may play a role. Infections with Epstein-Barr Virus (EBV) have been associated with a higher risk. Immune system deficiencies or suppression may increase susceptibility. Family history of Hodgkin lymphoma might slightly elevate risk.

Key Symptoms: Swollen lymph nodes that are painless, often in the neck, armpits, or groin. Fever that may come and go. Night sweats, especially severe and drenching. Unexplained weight loss over a short period. Itching all over the body. Persistent fatigue or feeling very tired. Pain in lymph nodes after drinking alcohol (less common).

Diagnosis Path: Diagnosis typically involves a combination of physical examinations, blood tests, imaging studies, and tissue biopsies. Lymph node biopsies are crucial for confirming the presence of Hodgkin lymphoma and determining its subtype. Pathologists look for Reed-Sternberg cells, a hallmark of Hodgkin lymphoma, and analyze the cellular makeup to identify mixed cellularity. Imaging tests like PET scans or CT scans help determine the extent of disease spread. Additional tests may be performed to assess overall health and organ function.

Treatment Protocols: Treatment approaches for mixed cellularity Hodgkin lymphoma often include combination therapies such as chemotherapy and radiation therapy. The specific regimen depends on the stage of the disease, patient health, and other factors. Chemotherapy protocols may involve drugs like ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) or other tailored regimens. In some cases, stem cell transplantation or immunotherapy might be considered. Regular follow-up and monitoring are essential to assess treatment response and manage any side effects. Supportive care, including infection prevention and management of treatment-related symptoms, is also a key component of overall treatment strategies.